Exact Mass: 367.3086276
Exact Mass Matches: 367.3086276
Found 102 metabolites which its exact mass value is equals to given mass value 367.3086276,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3, 5-Tetradecadiencarnitine
C21H37NO4 (367.27224420000005)
3, 5-Tetradecadiencarnitine is an acylcarnitine. More specifically, it is an (3E,5E)-tetradeca-3,5-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3, 5-Tetradecadiencarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 3, 5-tetradecadiencarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular 3, 5-tetradecadiencarnitine is elevated in the blood or plasma of individuals with CVD in type 2 diabetes mellitus (PMID: 32431666). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
N-Oleoyl GABA
N-Oleoyl GABA is considered to be practically insoluble (in water) and acidic. N-Oleoyl GABA is a fatty amide lipid molecule
(5Z,8Z)-Tetradecadienoylcarnitine
C21H37NO4 (367.27224420000005)
(5Z,8Z)-Tetradecadienoylcarnitine is an acylcarnitine. More specifically, it is an (5Z,8Z)-tetradecadienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5Z,8Z)-Tetradecadienoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (5Z,8Z)-Tetradecadienoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular (5Z,8Z)-Tetradecadienoylcarnitine is elevated in the blood or plasma of individuals with insulin resistance, type 2 diabetes (PMID: 24358186) and Alzheimer disease (PMID: 31785839). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(10Z,12E)-Tetradecadienoylcarnitine
C21H37NO4 (367.27224420000005)
(10Z,12E)-Tetradecadienoylcarnitine is an acylcarnitine. More specifically, it is an (10Z,12E)-tetradeca-10,12-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (10Z,12E)-Tetradecadienoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (10Z,12E)-Tetradecadienoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular (10Z,12E)-Tetradecadienoylcarnitine is elevated in the blood or plasma of individuals with insulin resistance, type 2 diabetes (PMID: 24358186) and Alzheimer disease (PMID: 31785839). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(6Z,9Z)-Tetradecadienoylcarnitine
C21H37NO4 (367.27224420000005)
(6Z,9Z)-Tetradecadienoylcarnitine is an acylcarnitine. More specifically, it is an (6Z,9Z)-tetradeca-6,9-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (6Z,9Z)-Tetradecadienoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (6Z,9Z)-Tetradecadienoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular (6Z,9Z)-Tetradecadienoylcarnitine is elevated in the blood or plasma of individuals with insulin resistance, type 2 diabetes (PMID: 24358186) and Alzheimer disease (PMID: 31785839). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2E,4E)-Tetradecadienoylcarnitine
C21H37NO4 (367.27224420000005)
(2E,4E)-Tetradecadienoylcarnitine is an acylcarnitine. More specifically, it is an (2E,4E)-tetradeca-2,4-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E,4E)-Tetradecadienoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (2E,4E)-Tetradecadienoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular (2E,4E)-Tetradecadienoylcarnitine is elevated in the blood or plasma of individuals with insulin resistance, type 2 diabetes (PMID: 24358186) and Alzheimer disease (PMID: 31785839). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
N-Linoleoyl Serine
C21H37NO4 (367.27224420000005)
N-linoleoyl serine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Serine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Serine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Serine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Macamide
n-Benzyl-(9z,12z,15z)-octadecatrienamide is a natural product found in Lepidium meyenii and Heliopsis helianthoides with data available. See also: Lepidium meyenii root (part of). N-?Benzyllinolenamide is a natural macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 41.8 μM[1]. N-?Benzyllinolenamide is a natural macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 41.8 μM[1].
4(1H)-Quinolinone, 1-methyl-2-(10Z)-10-pentadecenyl-
ethyl tumonoate A
C21H37NO4 (367.27224420000005)
A natural product found particularly in Oscillatoria margaritifera and Oscillatoria margaritifera.
1-methyl-2-[(Z)-5-pentadecenyl]-4(1H)-quinolone|1-methyl-2-[(Z)-5?-pentadecenyl]-4(1H)-quinolone
CAR 14:2
C21H37NO4 (367.27224420000005)
Benzalkonium chloride
C23H42ClN (367.30056020000006)
D013501 - Surface-Active Agents > D003902 - Detergents > D001548 - Benzalkonium Compounds C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
benzyl-dimethyl-tetradecan-2-ylazanium,chloride
C23H42ClN (367.30056020000006)
Dodecyl(ethylbenzyl)dimethylammonium chloride
C23H42ClN (367.30056020000006)
1-TERT-BUTYL-2,2,4,4,4-PENTAKIS(DIMETHYLAMINO)-2LAMBDA5,4LAMBDA5-CATENADI(PHOSPHAZENE)
6-methylheptyl prop-2-enoate,N-(2,4,4-trimethylpentan-2-yl)prop-2-enamide
(9Z,12Z)-N,N-bis(2-hydroxyethyl)octadeca-9,12-dien-1-amide
N-(4-Ethylbenzyl)-N,N-dimethyl-1-dodecanaminium chloride
C23H42ClN (367.30056020000006)
tetracosanoate
C24H47O2- (367.35758619999996)
A straight-chain saturated fatty acid anion that is the conjugate base of tetracosanoic acid (lignoceric acid), formed by deprotonation of the carboxy group.
N-[[3-(dimethylamino)phenyl]methyl]-1-[2-(4-methoxyphenyl)ethyl]piperidin-4-amine
C23H33N3O (367.26234880000004)
(5E,7E)-3-hydroxy-4-oxo-3-[(trimethylazaniumyl)methyl]heptadeca-5,7-dienoate
C21H37NO4 (367.27224420000005)
3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]propanoic acid
C21H37NO4 (367.27224420000005)
(10Z,12E)-Tetradecadienoylcarnitine
C21H37NO4 (367.27224420000005)
5-[[(2E,12E,15R)-15-hydroxyhexadeca-2,12-dienoyl]amino]pentanoic acid
C21H37NO4 (367.27224420000005)
N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]hexanamide
N-[(4E,8E)-1,3-dihydroxyicosa-4,8-dien-2-yl]acetamide
N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]octanamide
N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]butanamide
(Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tetradec-9-enamide
N-[(4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]pentanamide
N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]heptanamide
(Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]tridec-9-enamide
N-[(4E,8E)-1,3-dihydroxynonadeca-4,8-dien-2-yl]propanamide
N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]nonanamide
N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]decanamide
(5Z,8Z)-tetradecadienoylcarnitine
C21H37NO4 (367.27224420000005)
An O-tetradecadienoylcarnitine having (5Z,8Z)-tetradecadienoyl as the acyl substituent.
prostaglandin F2alpha dimethylamine
A member of the class of prostaglandins Falpha that is the dimethylamine derivative of prostaglandin F2alpha.
fatty acid anion 24:0
Any saturated fatty acid anion containing 24 carbons. Formed by deprotonation of the carboxylic acid moiety. Major species at pH 7.3.
O-tetradecadienoylcarnitine
C21H37NO4 (367.27224420000005)
An O-acylcarnitine in which the acyl group specified is tetradecadienoyl.
O-tetradecadienoyl-L-carnitine
C21H37NO4 (367.27224420000005)
An O-acyl-L-carnitine that is L-carnitine having a tetradecadienoyl group as the acyl substituent in which the positions of the two double bonds are unspecified.
2-methyl-6-(13-oxotetradecyl)piperidin-3-yl acetate
(1r,3r,6s,8r,12r,15z,16s)-15-ethylidene-7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one
1-[7,7,12,16-tetramethyl-6-(methylamino)tetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3,14-trien-15-yl]ethanone
ethyl (2s)-1-[(2r,3s)-3-hydroxy-2,4-dimethyldodec-4-enoyl]pyrrolidine-2-carboxylate
C21H37NO4 (367.27224420000005)
1-methyl-2-(10-pentadecenyl)-4(1h)-quinolinone
{"Ingredient_id": "HBIN002724","Ingredient_name": "1-methyl-2-(10-pentadecenyl)-4(1h)-quinolinone","Alias": "NA","Ingredient_formula": "C25H37NO","Ingredient_Smile": "NA","Ingredient_weight": "367.57","OB_score": "NA","CAS_id": "120693-50-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9168","PubChem_id": "NA","DrugBank_id": "NA"}
1-methyl-2-(6-pentadecenyl)-4(1h)-quinolinone
{"Ingredient_id": "HBIN002734","Ingredient_name": "1-methyl-2-(6-pentadecenyl)-4(1h)-quinolinone","Alias": "NA","Ingredient_formula": "C25H37NO","Ingredient_Smile": "CCCCCCCCC=CCCCCCC1=CC(=O)C2=CC=CC=C2N1C","Ingredient_weight": "367.57","OB_score": "NA","CAS_id": "120693-51-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9163","PubChem_id": "5319751","DrugBank_id": "NA"}
1-methyl-2-[(z)-9-pentadecenyl]-4-(1h)-quinolone
{"Ingredient_id": "HBIN002764","Ingredient_name": "1-methyl-2-[(z)-9-pentadecenyl]-4-(1h)-quinolone","Alias": "1-methyl-2-[(z)-9-pentadecenyl]-4(1h)-quinolone","Ingredient_formula": "C25H37NO","Ingredient_Smile": "CCCCCC=CCCCCCCCCC1=CC(=O)C2=CC=CC=C2N1C","Ingredient_weight": "367.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT19375;SMIT16692","TCMID_id": "31669;14650","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102003052","DrugBank_id": "NA"}
1-[7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadeca-8,14-dien-15-yl]ethanone
(1r,3r,6s,8r,12r,15e,16s)-15-ethylidene-7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one
1-[(1s,3s,6s,11s,12s,16s)-7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadeca-8,14-dien-15-yl]ethanone
(2r,3r,6s)-2-methyl-6-(13-oxotetradecyl)piperidin-3-yl acetate
5-{[(15r)-1,15-dihydroxyhexadeca-2,12-dien-1-ylidene]amino}pentanoic acid
C21H37NO4 (367.27224420000005)
1-[(1s,3r,6s,8r,11s,12s,16s)-6-(dimethylamino)-12,16-dimethyl-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-14-en-15-yl]ethanone
1-[(6s,8r,11r,12s,16s)-7,7,12,16-tetramethyl-6-(methylamino)tetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3,14-trien-15-yl]ethanone
1-[6-(dimethylamino)-12,16-dimethyl-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-14-en-15-yl]ethanone
1-benzoyl-2-methyl-3-(tridec-5-en-1-yl)-4,5-dihydropyrrole
ethyl 1-(3-hydroxy-2,4-dimethyldodec-4-enoyl)pyrrolidine-2-carboxylate
C21H37NO4 (367.27224420000005)